Strong Labor Data Sends Stocks Lower 📉

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. It's Thursday, January 5th. I hope you had a great day! Here's what moved the market today: Markets 📈 US benchmarks closed lower after stronger-than-expected labor market data raised fears of more interest rate hikes. The S&P 500 [-1.1%], Nasdaq [-1.4%], and Dow [-1.0%] took steep losses on the session, and the small-cap Russell 2K [-1.0%] followed them lower. Sponsored [Apple's EV Could Send this Tiny Stock to the Moon 🚀]( An Apple EV is coming, and it could change transportation as we know it. And while I don’t think it’s a bad idea to swipe up some Apple stocks right now... There’s a better under-the-radar opportunity... This $5 stock has potential to 40X once the Apple Car goes live. [Get All the Details Here]( Today's Market-Moving News 🔎 💼 Job Data Shows Tight Labor Market: U.S. jobless claims fell by 19,000 to a seasonally-adjusted 204,000 last weak, signalling historic tightness in the labor market and raising concerns that the Federal Reserve's hawkish rate push will continue for the foreseeable future. Today's Top Winners and Losers 🔥 Silvergate Capital [SI] $12.57 (-42.7%) Silvergate Capital announced preliminary Q4 results that showed the customer deposits dropped sharply in the wake of the FTX collapse. Bed Bath & Beyond [BBBY] $1.69 (-29.8%) Bed Bath & Beyond expressed "substantial doubt" about its ability to go on, and sources familiar with the matter say the company is preparing to file for bankruptcy within the next few weeks. Nuwellis [NUWE ://elitetra.de/L2Ic ] $8.16 (-25.4%) After Wednesday's closing bell, Nuwellis announced the passage of a warrant proposal for the issuance of 66.2 million shares of the company's common stock. Bellerophon Therapeutics [VVOS] $2.29 (+150.3%) Bellerophon Therapeutics announced a new license agreement for the commercialization of Inopulse® in Greater China with Baylor Biosciences ABVC BioPharma [ABVC] - Last Close: $1.07 (+39.4%) ABVC BioPharma announced the FDA had approved its investigation new drug application for a clinical study of ABV-1519 for the treatment of non-small cell lung cancer. Novocure [NVCR] $118.81 (+68.4%%) A LUNAR study of Novicure's Tumor Treating Fields in non-small cell lung cancer patients met its primary overall survival endpoint. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](